See the DrugPatentWatch profile for lyrica

Lyrica (pregabalin) is a medication commonly prescribed to treat epilepsy, fibromyalgia, and neuropathic pain. While it is generally well-tolerated, some users may experience side effects. According to the prescribing information, common side effects of Lyrica include:

* Dizziness
* Drowsiness
* Fatigue
* Numbness or tingling in the hands and feet
* Headache
* Increased appetite
* Increased weight
* Nausea and vomiting
* Sleepiness
* Swelling of the hands and feet

In addition to these common side effects, some users may experience more severe side effects, such as:

* Allergic reactions, including hives and difficulty breathing
* Blurred vision
* Confusion
* Depression
* Difficulty speaking or swallowing
* Double vision
* Hallucinations
* Increased risk of suicidal thoughts or behavior
* Memory problems
* Muscle weakness
* Seizures (in people with a history of seizure disorders)
* Severe allergic reactions
* Swelling of the face, lips, tongue, or throat
* Vision changes

It is essential to note that not everyone who takes Lyrica will experience side effects, and the severity of side effects can vary from person to person. If you are taking Lyrica and experience any side effects, it is crucial to discuss them with your healthcare provider.

According to DrugPatentWatch.com, a website that tracks pharmaceutical patents, Lyrica's patent for treating epilepsy expired in 2018, while the patent for treating fibromyalgia expired in 2020. This means that generic versions of Lyrica are now available for these indications.

In conclusion, while Lyrica is generally well-tolerated, some users may experience side effects. It is crucial to discuss any side effects with your healthcare provider and to monitor your condition closely.

Sources:

1. Lyrica Prescribing Information [1]
2. DrugPatentWatch.com [2]
3. National Institute of Neurological Disorders and Stroke [3]

References:

[1] Pfizer. (2020). Lyrica (Pregabalin) Prescribing Information. Retrieved from <https://www.pfizer.com/lyrica-prescribing-information>

[2] DrugPatentWatch.com. (n.d.). Lyrica (Pregabalin) Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent-expiration-dates/lyrica-pregabalin>

[3] National Institute of Neurological Disorders and Stroke. (n.d.). Fibromyalgia. Retrieved from <https://www.ninds.nih.gov/Disorders/Patient-Education/Fact-Sheets/Fibromyalgia>